{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:19:28Z","timestamp":1783937968726,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-026-02739-9","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:56:18Z","timestamp":1783936578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sustained metabolic control in latent autoimmune diabetes in adults (LADA) with semaglutide therapy in a patient with multiple autoimmune comorbidities: a case report and literature review"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5031-031X","authenticated-orcid":false,"given":"Settimio","family":"D\u2019Andrea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Berardicurti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Di Stasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Santarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Giorgio","family":"Baroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onorina","family":"Berardicurti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"6","key":"2739_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/dmrr.2779","volume":"32","author":"G Huang","year":"2016","unstructured":"Huang G, Yin M, Xiang Y, Li X, Shen W, Luo S, Lin J, Xie Z, Zheng P, Zhou Z (2016) Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up. Diab\/Metab Res Rev 32(6):615\u2013622. https:\/\/doi.org\/10.1002\/dmrr.2779","journal-title":"Diab\/Metab Res Rev"},{"key":"2739_CR2","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.2337\/dbi20-0017","volume":"69","author":"R Buzzetti","year":"2020","unstructured":"Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, Leslie R (2020) Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel. Diabetes 69:2037\u20132047. https:\/\/doi.org\/10.2337\/dbi20-0017","journal-title":"Diabetes"},{"issue":"6","key":"2739_CR3","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/dom.13237","volume":"20","author":"P Pozzilli","year":"2018","unstructured":"Pozzilli P, Leslie RD, Peters AL, Buzzetti R, Shankar SS, Milicevic Z, Pavo I, Lebrec J, Martin S, Schloot NC (2018) Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and \u2013\u20095 Trials. Diabetes Obes Metab 20(6):1490\u20131498. https:\/\/doi.org\/10.1111\/dom.13237","journal-title":"Diabetes Obes Metab"},{"key":"2739_CR4","doi-asserted-by":"publisher","first-page":"108270","DOI":"10.1016\/j.pharmthera.2022.108270","volume":"239","author":"S Shao","year":"2022","unstructured":"Shao S, Zhang X, Xu Q, Pan R, Chen Y (2022) Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities. Pharmacol Ther 239:108270. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108270","journal-title":"Pharmacol Ther"},{"issue":"1 Suppl 1","key":"2739_CR5","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.2337\/dc25-S009","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee (2025) 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025. Diabetes Care 48(1 Suppl 1):S181\u2013S206. https:\/\/doi.org\/10.2337\/dc25-S009","journal-title":"Diabetes Care"},{"key":"2739_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3803\/enm.2018.33.2.147","volume":"33","author":"P Pozzilli","year":"2018","unstructured":"Pozzilli P, Pieralice S (2018) Latent Autoimmune Diabetes in Adults: Current Status and New Horizons. Endocrinol Metabolism 33:147\u2013159. https:\/\/doi.org\/10.3803\/enm.2018.33.2.147","journal-title":"Endocrinol Metabolism"},{"key":"2739_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4093\/dmj.2018.0190","volume":"42","author":"S Pieralice","year":"2018","unstructured":"Pieralice S, Pozzilli P (2018) Latent Autoimmune Diabetes in Adults: A Review on Clinical Implications and Management. Diabetes Metabolism J 42:451\u2013464. https:\/\/doi.org\/10.4093\/dmj.2018.0190","journal-title":"Diabetes Metabolism J"},{"key":"2739_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2024.03.160","author":"S Gadve","year":"2024","unstructured":"Gadve S, Chavanda S, Gadve S, Chavanda K, Chavanda S, Hanamshetti S (2024) #1775120 Oral Semaglutide helps in maintaining \u03b2-cell function in patients with Recent-Onset Latent Autoimmune Diabetes in Adults: a 6 months Prospective Study. Endocr Pract. https:\/\/doi.org\/10.1016\/j.eprac.2024.03.160","journal-title":"Endocr Pract"},{"key":"2739_CR9","doi-asserted-by":"publisher","unstructured":"Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow,C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville,J., Grimshaw, J. M., Hr\u00f3bjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson,E., McDonald, S., McGuinness, L. A., \u2026 Moher, D. (2021). The PRISMA 2020 statement:an updated guideline for reporting systematic reviews. BMJ (Clinical research ed.),372, n71. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"issue":"1","key":"2739_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews. Syst reviews 5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst reviews"},{"issue":"2","key":"2739_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pan.2017.02.008","volume":"17","author":"S Haffar","year":"2017","unstructured":"Haffar S, Bazerbachi F, Prokop L, Watt KD, Murad MH, Chari ST et al (2017) Frequency and prognosis of acute pancreatitis associated with fulminant or non-fulminant acute hepatitis A: A systematic review. Pancreatology: official J Int Association Pancreatology (IAP) 17(2):166\u2013175. https:\/\/doi.org\/10.1016\/j.pan.2017.02.008","journal-title":"Pancreatology: official J Int Association Pancreatology (IAP)"},{"issue":"2","key":"2739_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","volume":"23","author":"MH Murad","year":"2018","unstructured":"Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ evidence-based Med 23(2):60\u201363. https:\/\/doi.org\/10.1136\/bmjebm-2017-110853","journal-title":"BMJ evidence-based Med"},{"issue":"3","key":"2739_CR13","doi-asserted-by":"publisher","first-page":"e55771","DOI":"10.7759\/cureus.55771","volume":"16","author":"A Da Porto","year":"2024","unstructured":"Da Porto A, Varisco E, Antonello M, Casarsa V, Sechi LA (2024) Semaglutide Treatment in Adult-Onset Autoimmune Diabetes: A Case Study With Long-Term Follow-Up and Periodic Evaluation of Beta-Cell Function. Cureus 16(3):e55771. https:\/\/doi.org\/10.7759\/cureus.55771","journal-title":"Cureus"},{"issue":"11","key":"2739_CR14","doi-asserted-by":"publisher","first-page":"e96335","DOI":"10.7759\/cureus.96335","volume":"17","author":"T Hirai","year":"2025","unstructured":"Hirai T, Kitada M, Endo K, Hayashi K, Suzuki T (2025) A Case of Slowly Progressive Type 1 Diabetes Mellitus (SPIDDM, Probable) Successfully Managed With Oral Semaglutide for Glycemic Control and Weight Management Accompanied by Changes in Eating Behavior. Cureus 17(11):e96335. https:\/\/doi.org\/10.7759\/cureus.96335","journal-title":"Cureus"},{"key":"2739_CR15","doi-asserted-by":"publisher","first-page":"109118","DOI":"10.1016\/j.clim.2022.109118","volume":"244","author":"B Yesildag","year":"2022","unstructured":"Yesildag B, Mir-Coll J, Neelakandhan A, Gibson CB, Perdue NR, Rufer C, Karsai M, Biernath A, Forschler F, Jin PW, Misun PM, Title A, Hierlemann A, Kreiner FF, Wesley JD, von Herrath MG (2022) Liraglutide protects \u03b2-cells in novel human islet spheroid models of type 1 diabetes. Clin Immunol (Orlando Fla) 244:109118. https:\/\/doi.org\/10.1016\/j.clim.2022.109118","journal-title":"Clin Immunol (Orlando Fla)"},{"key":"2739_CR16","doi-asserted-by":"publisher","unstructured":"Silko I, \u0412\u0438\u043a\u0442\u043e\u0440\u043e\u0432\u043d\u0430 \u0421, Nikonova T, \u0412\u0430\u0441\u0438\u043b\u044c\u0435\u0432\u043d\u0430 \u041d, Shestakova M, \u0412\u043b\u0430\u0434\u0438\u043c\u0438\u0440\u043e\u0432\u043d\u0430 \u0428 (2016) Incretins role in Latent autoimmune diabetes of adults pathogenesis, the possibility of therapy with combination of glucagon-like peptide-1 agonist (GLP-1) and insulin.Obesity and Metabolism. 13:3\u20136. https:\/\/doi.org\/10.14341\/omet201623-6","DOI":"10.14341\/omet201623-6"},{"issue":"2","key":"2739_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2337\/dc15-0258","volume":"39","author":"AG Jones","year":"2016","unstructured":"Jones AG, McDonald TJ, Shields BM, Hill AV, Hyde CJ, Knight BA, Hattersley AT, PRIBA Study Group (2016) Markers of \u03b2-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes. Diabetes Care 39(2):250\u2013257. https:\/\/doi.org\/10.2337\/dc15-0258","journal-title":"Diabetes Care"},{"key":"2739_CR18","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/dom.13237","volume":"20","author":"P Pozzilli","year":"2018","unstructured":"Pozzilli P, Leslie R, Peters A, Buzzetti R, Shankar S, Milicevic Z, P\u00e1v\u00f3 I, Lebrec J, Martin S, Schloot N (2018) Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD\u20102, \u20104 and \u20105 Trials. Diabetes 20:1490\u20131498. https:\/\/doi.org\/10.1111\/dom.13237","journal-title":"Diabetes"},{"issue":"4","key":"2739_CR19","doi-asserted-by":"publisher","first-page":"e962","DOI":"10.1210\/clinem\/dgae372","volume":"110","author":"AL Peters","year":"2025","unstructured":"Peters AL, Buzzetti R, Lee CJ, Pavo I, Liu M, Karanikas CA, Paik JS (2025) Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS. J Clin Endocrinol Metab 110(4):e962\u2013e969. https:\/\/doi.org\/10.1210\/clinem\/dgae372","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2739_CR20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMc2302677","volume":"389","author":"P Dandona","year":"2023","unstructured":"Dandona P, Chaudhuri A, Ghanim H (2023) Semaglutide in Early Type 1 Diabetes. N Engl J Med 389(10):958\u2013959. https:\/\/doi.org\/10.1056\/NEJMc2302677","journal-title":"N Engl J Med"},{"issue":"11","key":"2739_CR21","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1111\/dme.13142","volume":"33","author":"SV Hope","year":"2016","unstructured":"Hope SV, Knight BA, Shields BM, Hattersley AT, McDonald TJ, Jones AG (2016) Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic. Diabet medicine: J Br Diabet Association 33(11):1554\u20131558. https:\/\/doi.org\/10.1111\/dme.13142","journal-title":"Diabet medicine: J Br Diabet Association"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02739-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02739-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02739-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:56:18Z","timestamp":1783936578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-026-02739-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":21,"alternative-id":["2739"],"URL":"https:\/\/doi.org\/10.1007\/s00592-026-02739-9","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were conducted in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}